Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

KAPLAN_USMLE_STEP_1_LECTURE_NOTES_2018_BIOCHEMISTRY_and_GENETICS

.pdf
Скачиваний:
26
Добавлен:
29.01.2024
Размер:
10.81 Mб
Скачать

Part I Biochemistry

The drugs allopurinol (used for gout) and 6-mercaptopurine (antineoplastic) also inhibit PRPP amidotransferase. These drugs are purine analogs which must be converted to their respective nucleotides by HGPRT within cells.

The amino acids glycine, aspartate, and glutamine are used in purine synthesis.

Tetrahydrofolate is required for synthesis of all the purines.

Inosine monophosphate (contains the purine base hypoxanthine) is the precursor for AMP and GMP.

Bridge to Microbiology

Protozoan and multicellular parasites and many obligate parasites, such as Chlamydia, cannot synthesize purines de novo because they lack the necessary genes in the purine pathway. However, they have elaborate salvage mechanisms for acquiring purines from the host to synthesize their own nucleic acids

to grow.

Ribose 5-Phosphate

PRPP synthetase

PRPP

P

O P

P

 

 

R

 

 

 

 

AMP

_

 

 

 

 

 

 

_

 

 

 

Allopurinol nucleotide

 

 

 

IMP

 

PRPP

 

 

 

6-Mercaptopurine

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GMP

 

 

amidotransferase

nucleotide

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

P

 

NH2

 

 

 

 

 

 

 

5-Phosphoribosylamine

 

O

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

R

 

 

 

 

 

 

 

 

 

 

Glycine, aspartate, glutamine

 

 

 

 

 

 

THF as carbon donor

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inosine

 

 

P

 

 

O

Hypoxanthine

 

 

 

 

 

 

monophosphate (IMP)

 

 

 

R

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amino from

 

 

 

 

 

 

 

Amino from

 

 

 

 

 

 

 

glutamine

 

 

 

 

 

 

 

 

aspartate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GMP

 

 

 

 

 

 

 

 

 

 

 

AMP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allopurinol

 

HGPRT

 

 

 

Allopurinol nucleotide

 

 

 

6-mercaptopurine

 

 

 

 

 

 

 

 

6-Mercaptopurine nucleotide

 

 

 

PRPP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure I-18-4. De Novo Purine Synthesis

294

Chapter 18 Purine and Pyrimidine Metabolism

PURINE CATABOLISM AND THE SALVAGE ENZYME HGPRT

Excess purine nucleotides or those released from DNA and RNA by nucleases are catabolized first to nucleosides (loss of Pi) and then to free purine bases (release of ribose or deoxyribose). Excess nucleoside monophosphates may accumulate when:

RNA is normally digested by nucleases (mRNAs and other types of RNAs are continuously turned over in normal cells).

Dying cells release DNA and RNA, which is digested by nucleases.

The concentration of free Pi decreases as it may in galactosemia, hereditary fructose intolerance, and glucose-6-phosphatase deficiency.

Salvage enzymes recycle normally about 90% of these purines, and 10% are converted to uric acid and excreted in urine. When purine catabolism is increased significantly, a person is at risk for developing hyperuricemia and potentially gout.

Purine catabolism to uric acid and salvage of the purine bases hypoxanthine (derived from adenosine) and guanine are shown below.

 

 

HGPRT deficiency (Lesch-Nyhan syndrome)

 

 

 

• Spastic cerebral palsy

 

 

 

 

• Self-mutilation (hands, lips)

 

 

 

 

• Hyperuricemia and gout

 

 

 

 

• Early death

 

 

ATP, GTP

AMP

IMP

• X-linked (recessive)

 

High-energy compounds

 

 

 

 

 

DNA and RNA

 

GMP

 

 

Salvage

 

 

 

 

 

pathway

Pi

 

NH3

Ribose-P

 

HGPRT

 

 

(HPRT)

 

 

 

 

 

AMP

Adenosine

Inosine

 

Hypoxanthine

90%

 

Adenosine

Purine

 

 

 

 

 

deaminase

nucleoside

and

 

 

 

 

phosphorylase

or

GMP

 

Guanosine

Guanine

 

 

Pi

 

Ribose-P

 

Xanthine

 

 

 

 

 

Allopurinol

 

 

Excretion pathway

 

 

 

Xanthine oxidase

 

 

 

 

 

 

Adenosine deaminase (ADA) deficiency

Dietary purines converted to uric

 

 

10%

• Severe combined immunodeficiency

acid by enterocytes and added to

 

 

 

 

 

 

 

 

 

Uric acid

 

• Autosomal recessive

the blood for excretion in the urine

 

 

 

 

 

 

Figure I-18-5. Purine Excretion and Salvage Pathways

295

Part I Biochemistry

Bridge to Pharmacology

Thiazide diuretics (hydrochlorothiazide and chlorthalidone) may cause hyperuricemia.

Bridge to Pathology

Treatment of large tumors with chemotherapeutic regimens or radiation may cause “turnor lysis syndrome” and excessive excretion of uric acid, resulting in gout. The cause of the excessive uric acid is the destruction of the cancer cell’s nucleic acid into purines undergoing turnover.

Clinical Correlate

Gout

Acute gouty arthritis, seen most commonly in males, results from precipitation of monosodium urate crystals in joints. The crystals, identified as negatively birefringent and needle-shaped, initiate neutrophil-mediated and acute inflammation, often first affecting the big toe. Chronic gout may manifest over time as tophi (deposits of monosodium urate) in soft tissue around joints, leading to chronic inflammation involving granulomas.

Acute attacks of gout are treated with colchicine or indomethacin to reduce the inflammation.

Chronic hyperuricemia, because of underexcretion, is treated with a uricosuric drug (probenecid).

Overproduction of uric acid and chronic gout are treated with allopurinol.

296

Adenosine Deaminase Deficiency

High-Yield

 

Adenosine deaminase (ADA) deficiency, an autosomal recessive disorder, causes a type of severe combined immunodeficiency (SCID). Lacking both B-cell and T-cell function, children are multiply infected with many organisms (Pneumocystis carinii, Candida) and do not survive without treatment. Enzyme replacement therapy and bone marrow transplantation may be used. Experimental gene therapy trials have not yet yielded completely successful cures.

High levels of dATP accumulate in red cells of ADA patients and inhibit ribonucleotide reductase, thereby inhibiting the production of other essential deoxynucleotide precursors for DNA synthesis (see Figure I-18-3). Although it is believed that the impaired DNA synthesis contributes to dysfunction of T cells and B cells, it is not known why the main effects are limited to these cell types.

Hyperuricemia and Gout

High-Yield

 

Hyperuricemia may be produced by overproduction of uric acid or underexcretion of uric acid by the kidneys. Hyperuricemia may progress to acute and chronic gouty arthritis if uric acid (monosodium urate) is deposited in joints and surrounding soft tissue, where it causes inflammation. Uric acid is produced from excess endogenous purines as shown in Figure I-18-5, and is also produced from dietary purines (digestion of nucleic acid in the intestine) by intestinal epithelia. Both sources of uric acid are transported in the blood to the kidneys for excretion in urine.

Allopurinol inhibits xanthine oxidase and also can reduce purine synthesis by inhibiting PRPP amidotransferase, provided HGPRT is active (see Figure I-18-4). Hyperuricemia and gout often accompany the following conditions:

Lesch-Nyhan syndrome (no purine salvage)

Partial deficiency of HGPRT

Alcoholism (lactate and urate compete for same transport system in the kidney)

Glucose 6-phosphatase deficiency

Hereditary fructose intolerance (aldolase B deficiency)

Galactose 1-phosphate uridyl transferase deficiency (galactosemia)

Mutations in PRPP synthetase that lower Km

In the last 2 diseases, phosphorylated sugars accumulate, decreasing the available Pi and increasing AMP (which cannot be phosphorylated to ADP and ATP). The excess AMP is converted to uric acid.

Lesch-Nyhan Syndrome

High-Yield

 

Lesch-Nyhan syndrome is an X-linked recessive condition involving:

Near-complete deficiency of HGPRT activity

Mental retardation

Spastic cerebral palsy with compulsive biting of hands and lips

Hyperuricemia

Death often in first decade

Chapter 18 Purine and Pyrimidine Metabolism

Over 100 distinct mutations of the HGPRT gene located on the X chromosome have been reported to give rise to Lesch-Nyhan syndrome. These mutations include complete deletions of the gene, point mutations that result in an increased Km for hypoxanthine and guanine for the enzyme, and mutations that cause the encoded enzyme to have a short half-life.

Lesch-Nyhan Syndrome

The parents of a 9-month-old infant were concerned that their son appeared generally weak, had difficulty moving his arms and legs, repeatedly bit his lips, and frequently seemed to be in pain. The infant was brought to the pediatrician. The parents mentioned that since the baby was born, they often noticed tiny, orange-colored particles when they changed the infant’s diapers. Lab analysis of uric acid in urine was normalized to the urinary creatinine in the infant, and it was found that the amount was 3 times greater than

the normal range.

One of the earliest signs of Lesch-Nyhan syndrome is the appearance of orange crystals in diapers. They are needle-shaped sodium urate crystals. Without the salvaging of hypoxanthine and guanine by HGPRT, the purines are shunted toward the excretion pathway. This is compounded by the lack of regulatory control of the PRPP amidotransferase in the purine synthesis pathway, resulting in the synthesis of even more purines in the body. The large amounts of urate will cause crippling, gouty arthritis and urate nephropathy. Renal failure is usually the cause of death. Treatment with allopurinol will ease the amount of urate deposits formed.

Bridge to Pharmacology

Febuxostat is a nonpurine inhibitor of xanthine oxidase.

Bridge to Medical Genetics

There are a large number of known mutations in the HGPRT gene. These have varying effects on the Km for the enzyme product, generating varying degrees of severity. This concept is known as allelic heterogeneity.

297

Part I Biochemistry

Review Questions

Select the ONE best answer.

1.A 6-month-old boy becomes progressively lethargic and pale and shows delayed motor development. Laboratory evaluation reveals normal blood urea nitrogen (BUN), low serum iron, hemoglobin 4.6 g/dL, and leukopenia. His bone marrow shows marked megaloblastosis, which did not

respond to treatment with iron, folic acid, vitamin B12, or pyridoxine. His urine developed abundant white precipitate identified as orotic acid. The underlying defect causing the megaloblastic anemia in this child is most likely in which of the following pathways?

A.Homocysteine metabolism

B.Pyrimidine synthesis

C.Urea synthesis

D.Uric acid synthesis

E.Heme synthesis

2.Patients with Lesch-Nyhan syndrome have hyperuricemia, indicating an increased biosynthesis of purine nucleotides, and markedly decreased levels of hypoxanthine phosphoribosyl transferase (HPRT). The hyperuricemia can be explained on the basis of a decrease in which regulator of purine biosynthesis?

A.ATP

B.GDP

C.Glutamine

D.IMP

E.PRPP

3.A 12-week-old infant with a history of persistent diarrhea and candidiasis is seen for a respiratory tract infection with Pneumocystis jiroveci. A chest x-ray confirms pneumonia and reveals absence of a thymic shadow. Trace IgG is present in his serum, but IgA and IgM are absent. His red blood cells completely lack an essential enzyme in purine degradation. The product normally formed by this enzyme is

A.guanine monophosphate

B.hypoxanthine

C.inosine

D.xanthine

E.xanthine monophosphate

298

Chapter 18 Purine and Pyrimidine Metabolism

Items 4 and 5

The anticancer drug 6-mercaptopurine is deactivated by the enzyme xanthine oxidase. A cancer patient being treated with 6-mercaptopurine develops hyperuricemia, and the physician decides to give the patient allopurinol.

4.What effect will allopurinol have on the activity of 6-mercaptopurine?

A.Enhanced deactivation of 6-mercaptopurine

B.Enhanced elimination of 6-mercaptopurine as uric acid

C.Enhanced retention and potentiation of activity

D.Decreased inhibition of PRPP glutamylamidotransferase

5. Resistance of neoplastic cells to the chemotherapeutic effect of 6-mercaptopurine would most likely involve loss or inactivation of a gene encoding

A.thymidylate synthase

B.hypoxanthine phosphoribosyltransferase

C.purine nucleoside pyrophosphorylase

D.orotic acid phosphoribosyltransferase

E.adenosine deaminase

299

Part I Biochemistry

Answers

1.Answer: B. Accumulation of orotic acid indicates megaloblastic anemia arises because pyrimidines are required for DNA synthesis.

2.Answer: D. IMP is a feedback inhibitor of PRPP amidophosphoribosyl transferase, the first reaction in the biosynthesis of purines. IMP is formed by the HPRT reaction in the salvage of hypoxanthine.

3.Answer: C. The child most likely has severe combined immunodeficiency caused by adenosine deaminase deficiency. This enzyme deaminates adenosine (a nucleoside) to form inosine (another nucleoside). Hypoxanthine and xanthine are both purine bases, and the monophosphates are nucleotides.

4.Answer: C. Because allopurinol inhibits xanthine oxidase, the 6-mercaptopurine will not be deactivated as rapidly.

5.Answer: B. HPRT is required for activation of 6-mercaptopurine to its ribonucleotide and inhibition of purine synthesis. The other enzymes listed are not targets for this drug.

300

PART II

Medical Genetics

Single-Gene Disorders

1

Learning Objectives

Interpret scenarios about basic definitions

Use knowledge of major modes of inheritance

Understand important principles that can characterize single-gene diseases

BASIC DEFINITIONS

Chromosomes

Humans are composed of 2 groups of cells:

Gametes. Ova and sperm cells, which are haploid, have one copy of each type of chromosome (1–22, X or Y). This DNA is transmitted to offspring.

Somatic cells (cells other than gametes). Nearly all somatic cells are diploid, having 2 copies of each type of autosome (1–22) and either XX or XY.

Diploid cells

Homologous chromosomes. The 2 chromosomes in each diploid pair are said to be homologs, or homologous chromosomes. They contain the same genes, but because one is of paternal origin and one is of maternal origin, they may have different alleles at some loci.

X and Y chromosomes, or the sex chromosomes, have some homologous regions but the majority of genes are different. The regions that are homologous are sometimes referred to as pseudoautosomal regions. During meiosis-1 of male spermatogenesis, the X and Y chromosomes pair in the pseudoautosomal regions, allowing the chromosomes to segregate into different cells.

Genes

Gene. Physically a gene consists of a sequence of DNA that encodes a specific protein (or a nontranslated RNA; for example: tRNA, rRNA, or snRNA).

Locus. The physical location of a gene on a chromosome is termed a locus.

Alleles. Variation (mutation) in the DNA sequence of a gene produces a new allele at that locus. Many genes have multiple alleles.

Polymorphism. When a specific site on a chromosome has multiple alleles in the population, it is said to be polymorphic (many forms).

Note

Gene: basic unit of inheritance

Locus: location of a gene on a chromosome

Allele: different forms of a gene

Genotype: alleles found at a locus

Phenotype: physically observable features

Homozygote: alleles at a locus are the same

Heterozygote: alleles at a locus are different

Dominant: requires only one copy of the mutation to produce disease

Recessive: requires 2 copies of the mutation to produce disease

Note

Although the term alleles is used most frequently with genes, noncoding DNA can also have alleles of specific sequences.

303